Obesity and hypertension: Obesity medicine association (OMA) clinical practice statement (CPS) 2023

Clayton, Tiffany Lowe; Fitch, Angela; Bays, Harold

doi:10.1016/j.obpill.2023.100083

Cited by 12 publications

(1 citation statement)

References 170 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…pojavi aterosklerotskih lezija koronarnih krvnih sudova doprinose različiti mehanizmi koji prate gojaznost, kao što su povećan simpatički tonus, povećana koncentracija slobodnih masnih kiselina, povećan intravaskularni volumen, inflamacija, promene u koncentraciji lipoproteina. Takođe, kod gojaznih osoba česta je pojava povišenog arterijskog pritiska (33,34,35).…”

Section: Uloga Gojaznosti U Razvoju Kardiovaskularnih Oboljenjaunclassified

Obesity and consequent changes in the body

Kisić,

Puhalo-Sladoje,

Mirić

et al. 2021

View full text Add to dashboard Cite

Obesity is one of the most common chronic, non-infectious diseases in the world and our country, and it is characterized by excessive accumulation of fat tissue in the body and an increase in body weight. The increase in the number of obese people is an important global health problem. Obesity is associated with cardiometabolic and psychosocial comorbidities, and may also affect years of healthy life and reduce life expectancy. Numerous factors, such as biological predisposition, socioeconomic factors and environmental factors, interact and influence the development and maintenance of obesity. Excess adipose tissue in the body and its dysfunction is associated with inflammation and increased risk of metabolic, mechanical and mental complications. It is very important to monitor the incidence of obesity and its impact on the development of chronic non-communicable diseases and life expectancy due to the development and implementation of strategies to prevent the increase in the number of obese people.

show abstract

Section: Uloga Gojaznosti U Razvoju Kardiovaskularnih Oboljenjaunclassified